Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAAD-PVC: Catheter Ablation vs Anti-arrhythmic Drugs for PVCs
NCT07445334Recruiting
- Sponsor
- Western Sydney Local Health District
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised trial in Premature ventricular complexes (PVC) (2 arms), sponsored by Western Sydney Local Health District. Primary endpoint: Proportion of participants with >=80% reduction in PVC burden at 12 weeks. Started Mar 2026; status: recruiting.
02
Conditions
Premature ventricular complexes (PVC)
Beyond the preview
Go deeper on NCT07445334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445334.